The innate immune cells at the heart of kidney allograft rejection

被引:0
作者
Perkins, Griffith B. [1 ,2 ]
Zuiani, James D. [2 ]
Coates, P. Toby [1 ,2 ]
机构
[1] Royal Adelaide Hosp, Cent Northern Adelaide Renal Transplantat Serv, Adelaide, SA, Australia
[2] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
关键词
antibody-mediated rejection; innate allorecognition; single-cell sequencing; DONOR-SPECIFIC ANTIBODIES; NK CELLS;
D O I
10.1016/j.kint.2024.03.031
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:348 / 350
页数:3
相关论文
共 9 条
  • [1] Interleukin-21 promotes Type-1 activation and of CD56dimCD16bright natural killer cells during kidney allograft antibody- mediated rejection showing a new link between adaptive and innate humoral allo-immunity
    Bailly, Elodie
    Macedo, Camila
    Ossart, Jason
    Louis, Kevin
    Gu, Xinyan
    Ramaswami, Bala
    Bentlejewski, Carol
    Zeevi, Adriana
    Randhawa, Parmjeet
    Lefaucheur, Carmen
    Metes, Diana
    [J]. KIDNEY INTERNATIONAL, 2023, 104 (04) : 707 - 723
  • [2] PIRs mediate innate myeloid cell memory to nonself MHC molecules
    Dai, Hehua
    Lan, Peixiang
    Zhao, Daqiang
    Abou-Daya, Khodor
    Liu, Wentao
    Chen, Wenhao
    Friday, Andrew J.
    Williams, Amanda L.
    Sun, Tao
    Chen, Jianjiao
    Chen, Wei
    Mortin-Toth, Steven
    Danska, Jayne S.
    Wiebe, Chris
    Nickerson, Peter
    Li, Tengfang
    Mathews, Lisa R.
    Turnquist, Heth R.
    Nicotra, Matthew L.
    Gingras, Sebastien
    Takayama, Eiji
    Kubagawa, Hiromi
    Shlomchik, Mark J.
    Oberbarnscheidt, Martin H.
    Li, Xian C.
    Lakkis, Fadi G.
    [J]. SCIENCE, 2020, 368 (6495) : 1122 - +
  • [3] NK Cell Transcripts and NK Cells in Kidney Biopsies from Patients with Donor-Specific Antibodies: Evidence for NK Cell Involvement in Antibody-Mediated Rejection
    Hidalgo, L. G.
    Sis, B.
    Sellares, J.
    Campbell, P. M.
    Mengel, M.
    Einecke, G.
    Chang, J.
    Halloran, P. F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (08) : 1812 - 1822
  • [4] Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection
    Koenig, Alice
    Mezaache, Sarah
    Callemeyn, Jasper
    Barba, Thomas
    Mathias, Virginie
    Sicard, Antoine
    Charreau, Beatrice
    Rabeyrin, Maud
    Dijoud, Frederique
    Picard, Cecile
    Meas-Yedid, Vannary
    Olivo-Marin, Jean-Christophe
    Morelon, Emmanuel
    Naesens, Maarten
    Dubois, Valerie
    Thaunat, Olivier
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (02): : 479 - 494
  • [5] Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection
    Lai, Christina
    Chadban, Steven J.
    Loh, Yik Wen
    Kwan, Tony King-Tak
    Wang, Chuanmin
    Singer, Julian
    Niewold, Paula
    Ling, Zheng
    Spiteri, Alanna
    Getts, Daniel
    King, Nicholas Jonathan Cole
    Wu, Huiling
    [J]. KIDNEY INTERNATIONAL, 2022, 102 (05) : 1090 - 1102
  • [6] Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII plus innate immune cells in rejection
    Lamarthee, Baptiste
    Callemeyn, Jasper
    Van Herck, Yannick
    Antoranz, Asier
    Anglicheau, Dany
    Boada, Patrick
    Becker, Jan Ulrich
    Debyser, Tim
    De Smet, Frederik
    De Vusser, Katrien
    Eloudzeri, Maeva
    Franken, Amelie
    Gwinner, Wilfried
    Koshy, Priyanka
    Kuypers, Dirk
    Lambrechts, Diether
    Marquet, Pierre
    Mathias, Virginie
    Rabant, Marion
    Sarwal, Minnie M.
    Senev, Aleksandar
    Sigdel, Tara K.
    Sprangers, Ben
    Thaunat, Olivier
    Tinel, Claire
    Van Brussel, Thomas
    Van Craenenbroeck, Amaryllis
    Van Loon, Elisabet
    Vaulet, Thibaut
    Bosisio, Francesca
    Naesens, Maarten
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [7] Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
    Mayer, Katharina A.
    Budde, Klemens
    Halloran, Philip F.
    Doberer, Konstantin
    Rostaing, Lionel
    Eskandary, Farsad
    Christamentl, Anna
    Wahrmann, Markus
    Regele, Heinz
    Schranz, Sabine
    Ely, Sarah
    Firbas, Christa
    Schoergenhofer, Christian
    Kainz, Alexander
    Loupy, Alexandre
    Haertle, Stefan
    Boxhammer, Rainer
    Jilma, Bernd
    Boehmig, Georg A.
    [J]. TRIALS, 2022, 23 (01)
  • [8] The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics
    Naesens, Maarten
    Roufosse, Candice
    Haas, Mark
    Lefaucheur, Carmen
    Mannon, Roslyn B.
    Adam, Benjamin A.
    Aubert, Olivier
    Boehmig, Georg A.
    Callemeyn, Jasper
    Clahsen-van Groningen, Marian
    Cornell, Lynn D.
    Demetris, Anthony J.
    Drachenberg, Cinthia B.
    Einecke, Gunilla
    Fogo, Agnes B.
    Gibson, Ian W.
    Halloran, Philip
    Hidalgo, Luis G.
    Horsfield, Catherine
    Huang, Edmund
    Kikic, Zeljko
    Kozakowski, Nicolas
    Nankivell, Brian
    Rabant, Marion
    Randhawa, Parmjeet
    Riella, Leonardo, V
    Sapir-Pichhadze, Ruth
    Schinstock, Carrie
    Solez, Kim
    Tambur, Anat R.
    Thaunat, Olivier
    Wiebe, Chris
    Zielinski, Dina
    Colvin, Robert
    Loupy, Alexandre
    Mengel, Michael
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (03) : 338 - 349
  • [9] In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection
    Yagisawa, Takafumi
    Tanaka, Toshiaki
    Miyairi, Satoshi
    Tanabe, Kazunari
    Dvorina, Nina
    Yokoyama, Wayne M.
    Valujskikh, Anna
    Baldwin, William M., III
    Fairchild, Robert L.
    [J]. KIDNEY INTERNATIONAL, 2019, 95 (02) : 350 - 362